Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Global VAE (Vinyl Acetate Ethylene) Redispersible Polymer Powder Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global VAE (Vinyl Acetate Ethylene) market is anticipated to grow at a considerable CAGR during the forecast period. The VAE market is driven by smart city development and increased building of affordable housing facilities for the urban population. The growing urbanization, and high discretionary income levels are anticipated to have a positive impact on residential development projects which in turn will drive the market growth. The global VAE market is segmented based on application and end-user. Based on application, the VAE market is segmented into tiling & flooring, mortars, plastering, insulation systems, and others. Based on end-user, the VAE market is segmented into residential, commercial, and industrial. Geographically, the global VAE market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global VAE market include Wacker Chemie AG, The Dow Chemical Co., BASF SE, and Synthomer plc, among others.
Comprehensive research methodology of the global VAE market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global VAE market.
Insights about market determinants that are stimulating the global VAE market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
Key Topics Covered: 1. Report Summary 2. Market Overview and Insights 2.1. Scope of the Report 2.2. Analyst Insight & Current Market Trends 2.2.1. Key Findings 2.2.2. Recommendations 2.2.3. Conclusion 3. Market Determinants 3.1. Motivators 3.2. Restraints 3.3. Opportunities 4. Market Segmentation 4.1. Global VAE Market by Application 4.1.1. Tiling & Flooring 4.1.2. Mortars 4.1.3. Plastering 4.1.4. Insulation Systems 4.1.5. Other 4.2. Global VAE Market by End-User 4.2.1. Residential 4.2.2. Commercial 4.2.3. Industrial 5. Regional Analysis 5.1. North America 5.1.1. United States 5.1.2. Canada 5.2. Europe 5.2.1. UK 5.2.2. Germany 5.2.3. Italy 5.2.4. Spain 5.2.5. France 5.2.6. Rest of Europe 5.3. Asia-Pacific 5.3.1. China 5.3.2. India 5.3.3. Japan 5.3.4. Rest of Asia-Pacific 5.4. Rest of the World 6. Company Profiles 6.1. Benson Polymers Ltd. 6.2. Celanese Corp. 6.3. China Petrochemical Corp. 6.4. Dairen Chemical Corp. 6.5. H.B. Fuller Company 6.6. Richest Group Ltd. 6.7. Shanxi Sanwei Group Co., Ltd. 6.8. U.S. Adhesives, Inc. 6.9. Vinavil S.p.A. 6.10. Wacker Chemie AG
For more information about this report visit https://www.researchandmarkets.com/r/my5qo8
It's important to remember that as we watch the stock market crash and our personal net worth take a big hit. While that has certainly happened, it's important to note that the stock market isn't the economy.
The first half of 2022 has been rocky. But Goldman likes this group to bounce back.
Economist Larry Summers was right about inflation last year — so we asked him what he sees coming next for the U.S. economy.
Over the past month, the odds of a home price correction spiked. That's according to an analysis CoreLogic ran for Fortune this week.
Your retirement savings are $1 million. You want $100,000 of yearly retirement income, including Social Security. Is that doable without tons of risk?
When legends speak, people listen – and few investors match the legendary status of Ray Dalio. The founder of Bridgewater Associates has built his firm from a 2-room apartment operation into the world’s largest hedge fund, with more than $150 billion in assets under management, and a net gain exceeding $46 billion. Dalio believes that the next two to four years will see our global economic and political systems change in ways that are unpredictable now. And the key to survival, for investors, ma
(Bloomberg) -- The world’s richest nation is waking up to an unpleasant and unfamiliar sensation: It’s getting poorer.Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsElon Musk Gets Defensive Over Twitter Meme as Harassment Report SurfacesPutin’s War Means Russia’s Rich Aren’t Welcome at Davos AnymoreStocks Avert Bear Market, Slide for Seventh Week: Markets WrapAmericans’ col
Cathie Wood is a long-time Tesla bull, but the stock isn't the largest holding in Wood's ARK Innovation ETF anymore.
What happened The ride in Ford (NYSE: F) stock wasn't very smooth on Friday. The big American carmaker saw its shares decline by nearly 3% on a day when the S&P 500 index essentially traded sideways. A ruling from a court overseas was the key catalyst in that deceleration.
One day after Boeing (NYSE: BA) stock bounced higher on news of a big 737 plane sale to the parent company of British Airways and Iberia (the International Consolidated Airlines Group), shares of the airplane-building juggernaut are falling 7.2% as of 1:10 p.m. ET. The reason: Boeing may be encountering turbulence at higher altitudes. Earlier on Thursday, the big news around Boeing was the company's announcement that International Airlines Group has agreed to buy 25 Boeing 737-8-200 aircraft and 25 737 MAX 10 jetliners -- and taken out an option to buy as many as 100 more planes besides.
Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) are no longer big winners for investors. Let's first address the uncertainties for Moderna. There are questions about the high number of side effects of its experimental influenza vaccine.
High-yield dividend stocks have been viewed more favorably than high-multiple growth stocks these days. After yet another month of excessive market-wide selling, the yields of many top dividend stocks are slightly richer. As the Fed raises interest rates further, growth and value could continue to get slammed. This week, the Fed signaled that it's more than willing to keep the rate hikes coming until inflation backs down, even if it means jeopardizing a "soft landing" and inflicting more pain in
In this article, we discuss 10 buy-the-dip stocks to buy according to billionaire Ken Fisher. If you want to skip our detailed analysis of Fisher’s stock selection and the current sell-off in tech, go directly to 5 Best Buy-the-Dip Tech Stocks According to Billionaire Ken Fisher. The tech-heavy Nasdaq Composite is down 27% in 2022 […]
The Dow Jones reversed higher while the S&P 500 battled out of bear market territory. Tesla stock dived amid reports about CEO Elon Musk.
(Bloomberg) -- It’s been hard to watch, impossible to predict and a nightmare to trade. But has the S&P 500’s slide been an unqualified panic to date? By some measures no, and that might bode poorly for equities in the near term. Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsElon Musk Gets Defensive Over Twitter Meme as Harassment Report SurfacesPutin’s War Means Russia’s
Mark Newton, head of technical strategy at Fundstrat, thinks the S&P 500's late-day reversal on Friday provides 'hopes that a minor bounce is underway.'
These fast-growing stocks are ripe for the picking following a nearly 30% peak decline in the Nasdaq.
There are lots of ways to generate passive income. Investing in dividend stocks is one of the tried-and-true approaches. Buying $100,000 of each of these 5 dividend stocks can make you nearly $33,000 in passive income per year.
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceuticals, 15%. A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge.
If you follow the large U.S.-based cryptocurrency exchange Coinbase (NASDAQ: COIN), you probably know that the stock has been getting crushed this year. Since going public a little more than a year ago, shares of Coinbase are down more than 80%. Let's look at why Coinbase's stock is down so much and whether or not it's a buy.